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Objectives: To relate cardiovascular magnetic resonance–derived segmental wall motion and myocardial scar-
ring and determine whether they are associated with postoperative mitral regurgitation following coronary artery
bypass grafting and annuloplasty for severe functional ischemic mitral regurgitation.
Methods: From January 2001 to October 2006, 29 patients with grade 3þchronic functional ischemic mitral
regurgitation were studied using cardiovascular magnetic resonance. Wall motion abnormality was graded for
17 standard left ventricular myocardial segments (0 ¼ none, 1þ¼ hypokinesis, 2þ¼ severe hypokinesis, 3þ¼
akinesis, 4þ¼ dyskinesis), as was degree of hyperenhancement (scarring). Postoperative mitral regurgitation
was assessed longitudinally by 71 transthoracic echocardiograms.
Results: Wall motion abnormalities grade 2þwere present in most myocardial segments (median 13). Scar
>25% was present in a median of 3 segments, and 44% of those were in the territory of the posterior papillary
muscle. Nearly all segments (95%) with>25% scar had2þwall motion abnormality. Although 90% of patients
had no mitral regurgitation at hospital discharge, by 6 months, 34% had mitral regurgitation grade 2þ. There
was little association between wall motion abnormality and recurrence of mitral regurgitation (P> .1). Seventy
percent of patients with scar>25% in the posterior papillary muscle region exhibited postoperative mitral regur-
gitation of grade 2þby 6 months, compared with 15% with score 25% (P ¼ .07).
Conclusions: In a pilot study of cardiovascular magnetic resonance imaging in severe functional ischemic mitral
regurgitation, severity of posterior papillary muscle region scarring correlated with decreased segmental wall mo-
tion and mitral regurgitation early after coronary revascularization and annuloplasty. Routinely assessing scar
burden may identify patients for whom annuloplasty alone is insufficient to eliminate mitral regurgitation.
ACQUIRED CARDIOVASCULAR DISEASESupplemental material is available online.
The mechanism for persistent or recurrent regurgitation after
coronary artery bypass grafting (CABG) and annuloplasty
for severe functional ischemic mitral regurgitation (MR) is
unclear. It is likely related to acute hemodynamic changes
and continued left ventricular (LV) remodeling.1-4 This pro-
cess represents the reversible and irreversible consequences
of coronary artery disease and therefore does not affect all
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ment of segmental myocardial dysfunction and scarring
with cardiac magnetic resonance (CMR) imaging may
shed light on the mechanism and identify patients for
whom concomitant annuloplasty alone is insufficient to
eliminate MR.5 Therefore, purposes of this pilot CMR clin-
ical investigation were to (1) relate regional wall motion
abnormalities to degree of myocardial scarring, and (2)
determine if either or both play a role in return of MR follow-
ing CABG and conventional mitral annuloplasty.
PATIENTS AND METHODS
Patients
From January 2001 to October 2006, 29 patients scheduled for primary
CABG and mitral annuloplasty for chronic severe functional ischemic MR
at Cleveland Clinic were studied by CMR imaging. All had grade 3þor 4þ
MR and a myocardial infarction that had occurred more than 30 days before
operation (Table 1). Clinical data were retrieved from the prospective Car-
diovascular Information Registry and follow-up echocardiographic findings
from the Echocardiography Registry. These registries have been approved
for use in research by the Institutional Review Board, with patient consent
waived.
Regional Wall Motion and Scarring
Wall motion abnormalities and myocardial scar severity were assessed
within 30 days of operation using CMR for each of 17 standard LV myocar-
dial segments (Figure 1).6 Images were acquired on a 1.5-T Siemens Sonatardiovascular Surgery c Volume 137, Number 5 1063
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DAbbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CMR ¼ cardiac magnetic resonance
LAD ¼ left anterior descending coronary artery
LCx ¼ left circumflex coronary artery
LV ¼ left ventricular
MR ¼ mitral regurgitation
RCA ¼ right coronary artery
system (Siemens Medical Solutions, Malvern, Pa) using a phased-array coil
during repeated breath-holds of approximately 8 seconds.
Steady-state free precession CMR images were acquired in short-axis
planes every 1 cm through the entire LV and in 3 long-axis planes. Segmen-
tal wall motion was graded as follows: 0, normal; 1, mild or moderate hy-
pokinesia; 2, severe hypokinesia; 3, akinesia; and 4, dyskinesia.7
Gadolinium chelate (gadopentetate dimeglumine, 0.2 mmol $ kg-1) was
administered and contrast-enhanced images acquired after 10 minutes
with a segment inversion recovery technique in identical planes. Segmental
gadolinium enhancement, interpreted as myocardial scar, was scored as fol-
lows: 0, 0% hyperenhanced; 1, 1% to 25% hyperenhanced; 2, 26% to 50%
hyperenhanced; 3, 51% to 75% hyperenhanced; and 4, 76% to 100% hy-
perenhanced.7 Previous investigators, using this scoring system, have found
a high likelihood of functional improvement or recovery following revascu-
larization in segments with<50% enhancement and low likelihood of func-
tional improvement in segments with>50% enhancement.7
CMR-derived segmental wall motion and scarring data were approved
for use in research by the Institutional Review Board, with patient consent
waived.
Postoperative MR
Postoperative MR was assessed using all in-hospital and postdischarge
transthoracic echocardiograms performed at Cleveland Clinic. Seventy-
six echocardiograms were available for analysis (Figure E1, A). Median
time of echocardiographic assessment was 3.5 months, and data were con-
sidered reliable to 2 years. Regurgitation was graded qualitatively as 0,
none; 1þ, mild; 2þ, moderate; 3þ, moderately severe; and 4þ, severe.
Data Analysis
All analyses were performed using SAS statistical software (SAS v9.1,
SAS Inc, Cary, NC).
Regional wall motion and scarring. Distribution of mean wall
motion grade and mean scar scores was constructed for each myocardial seg-
ment. These were averaged over major epicardial coronary artery territories
as follows (Figure 1): left anterior descending coronary artery (LAD) terri-
tory: segments 1, 2, 7, 8, 13, 14, and 17; right coronary artery (RCA)
territory: segments 3, 4, 9, 10, and 15; left circumflex coronary artery
(LCx) territory: segments 5, 6, 11, 12, and 16. They were also averaged
over the regions from which the anterior papillary muscle (segment 12)
and posterior papillary muscle (segments 10 and 11) typically arise, even
in the setting of LV enhancement.
Correlation was determined between mean wall motion grade and mean scar
score for each segment, coronary artery territory, and papillary muscle region.
Postoperative MR. We estimated the percentage of patients in each
MR grade across time by longitudinal temporal decomposition. A nonlinear
cumulative logit mixed model8 was used to resolve number of temporal
components and estimate-shaping parameters for each. To accommodate re-
peated echocardiographic assessments, each temporal component was inde-
pendently modulated by a time function with a common random intercept.
Because of the low-frequency occurrence of MR grade 3þ or 4þ, these1064 The Journal of Thoracic and Cardiovascular Sugrades were combined with grade 2þ. A focused bivariable analysis was per-
formed to determine the association of regional wall motion abnormalities
and scarring with postoperative MR.
Presentation. Continuous data are summarized by mean  standard
deviation and categorical data by frequency and percentage. Uncertainty
is expressed by 68% confidence limits equivalent to 1 standard error.
TABLE 1. Preoperative characteristics and operative details of patients
with chronic ischemic mitral regurgitation having cardiovascular
magnetic resonance imaging (n ¼ 29)
Variable No. (% of 29)
Male 21 (72)
Mean age (y), mean  SD 67  8.8
New York Heart Association functional class
I 4 (14)
II 14 (48)
III 9 (31)
IV 2 (6.9)
Coronary system disease (stenosis>50%)
Left main 7 (24)
LAD 26 (90)
RCA 24 (83)
LCx 23 (79)
Number of systems diseased
0 (left main) 1 (3.4)
1 2 (6.9)
2 7 (24)
3 19 (66)
Mitral regurgitation (grade)
3þ 19 (66)
4þ 10 (34)
LV ejection fraction (%), mean  SD 22  8
Noncardiac comorbidities
Diabetes mellitus (pharmacologically treated) 7 (24)
Peripheral arterial disease 18 (62)
Smoking 20 (69)
Hypertension 17 (59)
Procedure
Graft location
RCA 23 (79)
LAD 26 (90)
LCx 25 (86)
Number of ITA grafts used
0 3 (10)
1 24 (83)
2 2 (6.9)
Mitral annuloplasty
Ring size (mm)
24 1 (3.4)
26 14 (48)
28 13 (45)
30 1 (3.5)
Complete ring 7 (24)
Tricuspid annuloplasty 4 (14)
Cardiac resynchronization 3 (10)
ITA, Internal thoracic artery; LAD, left anterior descending coronary artery; LCx, left
circumflex coronary artery; LV, left ventricular; RCA, right coronary artery; SD, stan-
dard deviation.rgery c May 2009
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DFIGURE 1. Standard myocardial segments for assessing wall motion and scarring. Left, Short-axis depiction of segments; outer ring contains basilar seg-
ments; middle ring, mid-myocardial segments at papillary muscle level; inner ring, apical segments. Middle, Superimposed are territories of the left anterior
descending coronary artery (LAD), right coronary artery (RCA), and left circumflex coronary artery (LCx). Right, Regions of the anterior and posterior pap-
illary muscles. Ant. PM, Anterior papillary muscle; Post. PM, posterior papillary muscle.RESULTS
Regional Wall Motion and Scarring
Wall motion abnormalities grade 2þwere present in the
majority of LV segments (median 13 of 17; Figure 2). In the
LAD territory, the median number of segments exhibiting
a wall motion abnormality was 7 of 7, with 6 of 7 being
grade 2þ. Average LAD mean wall motion grade was
2.1 0.71. In the RCA territory, the median number of seg-
ments exhibiting a wall motion abnormality was 5 of 5, with
all being grade 2þ. Average RCA mean wall motion grade
was 2.3  0.65. In the LCx territory, the median number of
segments exhibiting a wall motion abnormality was 5 of 5,
with 3 of 5 being grade 2þ. Average LCx mean wall mo-
tion grade was 1.6  0.70. In the region of the anterior pap-The Journal of Thoracic and Caillary muscle, 25 patients (90%) exhibited a wall motion
abnormality, with 14 (48%) grade2þ; average wall motion
grade was 1.4 0.78. In the region of the posterior papillary
muscle, 28 patients (97%) exhibited a wall motion abnor-
mality, with 26 (90%) grade 2þ; average of all patients’
mean wall motion grade was 2.3  0.83.
Scar>25% was present in a median of 3 of 17 LV seg-
ments. Distribution of scar was most varied in the LAD ter-
ritory, less so in the RCA territory, and least in the LCx
territory (Figure 3). In the region of the anterior papillary
muscle, no patient exhibited scar>25%. In the region of
the posterior papillary muscle, 8 patients (28%) exhibited
scar>25%. In all, 44% of scars>25% were in the region
of the posterior papillary muscle.FIGURE 2. Distribution of mean wall motion grades overall and in territories of the left anterior descending coronary artery (LAD), right coronary artery
(RCA), left circumflex coronary artery (LCx), and regions of the anterior papillary muscle (Ant. PM) and posterior papillary muscle (Post. PM).rdiovascular Surgery c Volume 137, Number 5 1065
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DFIGURE 3. Distribution of mean scar scores overall and in territories of the left anterior descending coronary artery (LAD), right coronary artery (RCA), left
circumflex coronary artery (LCx), and regions of the anterior papillary muscle (Ant. PM) and posterior papillary muscle (Post. PM).If segmental wall motion was normal, generally no scarring
was detected, as shown for representative segments by bubble
plots (Figure 4). However, when segmental wall motion was
abnormal, extent of scarring was highly variable. This resulted
overall in low correlation between wall motion abnormality
and scar (r¼ .066, Figure 5); however, when examined within
coronary artery territories, increasing wall motion abnormality
correlated modestly with increasing scar in the LAD territory
(r¼ .46) and strongly in the LCx territory (r¼ .68). Correla-
tion was strong in the region of the anterior papillary muscle
(r ¼ .56, P ¼ .001) and modest in the region of the posterior
papillary muscle (r ¼ .42, P ¼ .02).
Postoperative MR
The temporal pattern of postoperative MR was character-
ized by 2 phases: an early rapid change over the first 3 to 6
months and a constant phase thereafter (Figure E2). The per-
centage of patients with no MR decreased rapidly from
about 90% 1 day after surgery to 19% 6 months later; the
percentage of patients in MR grade 1þ increased from
10% to 49%; and the percentage of patients in MR grade
2þ/3þ/4þ increased from 0% to 34% (Figure 6).
Postoperative MR was unrelated to overall LV wall mo-
tion abnormality and scarring (P  .5), and the same was
true for each coronary artery territory (P  .2). However,
when wall motion abnormality and scarring were examined
segmentally, wall motion grade 2þ to some extent (P ¼
.07) and scar>25% (P ¼ .05) in the midinferior segment
(portion of the posterior papillary muscle in RCA territory)1066 The Journal of Thoracic and Cardiovascular Swere associated with greater return of early postoperative
MR. Figure 7 demonstrates the substantial impact of scar
>25% on postoperative MR for the posterior papillary mus-
cle region compared with no, or 25% or less, scarring in this
same region (see Figure E1, B and C for number of patients
and echocardiograms available for analysis).
DISCUSSION
Principal Finding
The main finding of this study is that extensive scarring
and severe wall motion abnormalities in the region of poste-
rior papillary muscle, identified by preoperative CMR imag-
ing in patients with ischemic cardiomyopathy, correlate with
MR after CABG and mitral annuloplasty.
Ischemic cardiomyopathy is the most common cause of
heart failure in the United States. This advanced form of cor-
onary artery disease is marked by diffuse myocardial damage
causing LV remodeling. Functional ischemicMR isa common
consequence of LV remodeling, with resulting decrease in mi-
tral leaflet coaptation.9,10 Contemporary surgical treatment
consists of CABG and correction of MR by mitral anulo-
plasty.11,12 Although CABG has resulted in improved survival
compared with medical therapy, the efficacy of mitral annulo-
plasty has been disappointing because of a high rate of postop-
erative MR persistence or recurrence.13,14
We postulate that extensive scarring in the region of the
posterior papillary muscle is a likely cause of failure of
CABG and annuloplasty to correct functional ischemic
MR. Although preoperative assessment of myocardialurgery c May 2009
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outcome of coronary revascularization, it has not been
used routinely as a guide in treating patients with chronic
functional ischemic MR.15
Echocardiographic assessment of LV contractility has
been demonstrated to be a useful and reliable predictor of
operative risk and postoperative outcomes in patients with
ischemic cardiomyopathy.11,13 However, wall motion ab-
normalities can result from irreversible myocardial damage
following myocardial infarction or from reversible dysfunc-
tion from ischemia or hibernation. CMR imaging has the
advantages of providing information about both myocardial
contractility and degree of scarring, as well as anatomic and
functional assessment of the mitral valve.15
Patients in our study had advanced ischemic cardiomyop-
athy and severely depressed LV function, with diffuse
regional wall motion abnormalities. Overall extent of re-
gional wall motion abnormalities was greater than the degree
of scarring, suggesting a large amount of viable, but dys-
functional, myocardium. The important finding is that
even minimal scarring causes regional wall motion abnor-
malities, but overall extent of scarring correlates poorly
with severity of wall motion abnormalities. This correlation
was particularly poor in the LAD territory, which might be
explained by good collateral blood supply there. The pos-
terolateral wall, which is predominantly supplied by the
LCx, has less collateral circulation in patients with diffuse
3-system coronary artery disease, making it more prone to
scarring, with resulting high correlation between amount
of scarring and regional wall motion abnormalities.16
Recent clinical and experimental studies highlight the
importance of the posterior papillary muscle function in
development of functional ischemic MR.9,10,17 Ischemia
or infarction in the region of the posterior papillary muscle
causes apical leaflet systolic restriction, which, along with
annular dilatation, causes leaflet malcoaptation in func-
tional ischemic MR. Severe scarring in the region of the
posterior papillary muscle was strongly associated with
recurrent postoperative MR in our patients. A possible
explanation is that undersized mitral annuloplasty, used in
our patients, corrects annular dilatation but does not address
apical leaflet systolic restriction caused by papillary muscle
dysfunction.11,13,14 Reversible dysfunction of ischemic
posterior papillary muscle can be corrected by CABG;
however, this will be ineffective if severe myocardial
scarring is present.
Limitations
This is a single-institution pilot study performed during
a 5-year span. CMR imaging was obtained in a small number
of patients with ischemic cardiomyopathy and functional is-
chemic MR; thus, our findings cannot be generalized. No
patient had postoperative CMR imaging, and postoperative
echocardiography was performed based on clinical indica-The Journal of Thoracic and Ctions. Estimates of regurgitation were qualitative and did
not include quantitative assessments such as regurgitant
fraction or other volume indices. The study was not powered
FIGURE 4. Bubble plots depicting wall motion grade and scar score in
representative segments of each coronary artery territory. A, Midanterior
segment (17) of left anterior descending coronary artery territory. B, Midin-
ferior segment (10) of right coronary artery territory (and a portion of region
of posterior papillary muscle). C, Midinferolateral segment (11) of left cir-
cumflex coronary artery territory (and a portion of region of the posterior
papillary muscle).ardiovascular Surgery c Volume 137, Number 5 1067
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artery; RCA, right coronary artery; LCx, left circumflex coronary artery.to investigate the possible role of type of ring annuloplasty
or return of MR.
Choice of operative procedures was surgeon dependent.
Most patients received an undersized flexible annuloplasty
band, and only a few, a complete rigid ring.
Clinical Implications
Preoperative CMR imaging should be considered for all
patients with severe ischemic cardiomyopathy and func-1068 The Journal of Thoracic and Cardiovascular Stional ischemic MR. Current standard CMR protocols allow
accurate assessment of LV dimensions, contractility, and
scar burden, as well as mitral valve anatomy and function.
Analyzing regional wall motion abnormalities and scarring
is time consuming and elaborate and will require further
standardization and software improvement.
CABG and concurrent mitral annuloplasty are ineffective
for severe scarring in the region of the posterior papillary
muscle, as detected by preoperative CMR imaging.18-20FIGURE 6. Temporal trend of postoperative mitral regurgitation (MR)
grades across time. Solid lines are parametric estimates of percentages of pa-
tients in each MR grade after surgery, and symbols represent data grouped
within unequal time intervals without regard to repeated assessment, to pro-
vide a crude verification of model fit. Solid lines are enclosed within 68%
confidence limits obtained by bootstrap percentile method.21FIGURE 7. Association of postoperative mitral regurgitation (MR) grade
2þwith scar score>25% versus 25% in region of posterior papillary
muscle. Depiction is as in Figure 6.urgery c May 2009
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Discussion
Dr R. Dion (Genk, Belgium). Dr Flynn, I would like to congrat-
ulate you for the quality of your presentation, and the authors andThe Journal of Thoracic and Cfriends from the Cleveland Clinic have to be commended for an
original pilot study trying to elucidate the relation between wall
motion abnormality and scarring and return of MR. CMR was
used, which is certainly very elaborate and time-consuming; there-
fore, one should not underestimate the task of applying CMR and
analyzing it in 29 patients.
The main finding of this study is that extensive scarring, and se-
vere wall motion abnormality to a lesser extent because it is less sig-
nificant in the region of the posterior papillary muscle, correlates
with the return of MR.
My first question concerns the preoperative myocardial infarc-
tion. All 29 patients had a history of myocardial infarction. Could
you specify in which coronary territory? Was it mainly in the region
of the right coronary and the circumflex, as expected, and did it al-
ways correlate with the site of scarring on CMR?
Dr Flynn. Thank you for your kind comments and your good
questions. First, the most predominant area of infarction was in-
ferior, in the right coronary territory. We did not investigate
whether the degree of CMR-assessed scarring correlated with
the presence of myocardial ischemia. We do not have evidence
on that.
Dr Dion. I ask because the LAD mean wall motion was grade
2.1. It was grade 2.3 for the RCA and the posterior papillary mus-
cle, but it was only grade 1.6 for the circumflex and the anterior
papillary muscle. So there was more wall motion abnormality in
the anterior part of the heart than in the territory of the circumflex.
There was also more scar in the LAD than in LCx and in the anterior
papillary muscle territory, which is a bit surprising for me, because
I would have expected more scarring in the territory of the circum-
flex than in the LAD.
However, in the Discussion you state ‘‘the posterolateral wall,
which is predominantly supplied by the LCx, has less collateral cir-
culation in patients with diffuse 3-system coronary artery disease,
making it more prone to scarring, with resulting high correlation be-
tween amount of scarring and regional wall motion abnormalities.’’
But again, the mean scar score is less than 2 in the circumflex ter-
ritory. Can you elaborate on that?
Dr Flynn. Indeed. We feel that the most relevant territory is
possibly that of the right coronary, and to relate this to scarring
or dysfunction in the posterior papillary and the fact that it may
be supplied by 2 territories, as you are aware: if there is disease
or coronary disease related to both of those territories, these are
the patients who are at risk and who possibly have a greater
degree of scarring in the posterior papillary region. And these
are possibly the patients then, as we have demonstrated here,
who have a higher rate of recurrence of ischemic MR after
surgery.
Dr Dion. Thank you. Forty-four percent of the patients had
a scar of more than 25% in the posterior papillary muscle, but
the posterior papillary was attributed 2 segments and the anterior
papillary muscle, only 1 segment. Could it have influenced the
results? Why did you decide that the anterior papillary muscle
would be 1 segment and the posterior papillary muscle 2 seg-
ments?
Dr Flynn. Well, we know from science and nature that the pos-
terior papillary is related to 2 coronary territories. We feel that dis-
ease involving both of those coronary territories makes the
posterior papillary more at risk for infarction and a greater determi-
nant of dysfunction.ardiovascular Surgery c Volume 137, Number 5 1069
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recurrent MR at 6 months. It is probably explained by the fact that
the choice of the procedure was left at the discretion of the surgeon,
but, on the other hand, it allowed your group to perform this study
with ‘‘only’’ 29 patients. What do you think about the temporal pat-
tern of postoperative MR in 2 phases? I found it very interesting and
very intriguing. Why such an increase in the first 3 months and after
that, stabilization? How do you interpret that?
Dr Flynn. As you are aware, this represents a valvular approach
to a ventricular problem, and this may reflect the fact that annulo-
plasty in these patients, particularly those who got scarring in
that papillary region, may not be the appropriate approach for these
patients. I think to study the overall temporal occurrence of MR was
not within the remit of this study. It wasn’t designed for that pur-
pose; it wasn’t powered for that purpose. So we have not studied
or assessed the temporal degeneration of MR.
Dr. Dion. And finally, I found your conclusion quite severe for
restrictive mitral annuloplasty. You state, ‘‘CABG and concurrent
mitral annuloplasty are ineffective for severe scarring in the region
of the posterior papillary muscle.’’ But even in your setup, 30% of
the patients with severe scarring of the posterior papillary muscle
had no recurrent MR, and 15% with little scarring in the posterior
papillary muscle had recurrent MR. Don’t you think that, besides
the scarring and the wall motion abnormality, you should have
taken into account the LV dilatation? Maybe there is a relation be-
tween the extent of scarring and the LV dilatation, which might ex-
plain that without scarring and with LV dilatation you could have
recurrent MR.
Dr Flynn. I think your comments are well received. I think these
are different ways of looking at very sick patients. These are differ-
ent means of looking at severe LV dysfunction. Yes, indeed, LV
end-diastolic diameter is 1 parameter that can be used. Our mean
LV end-diastolic diameter was 62 mm, but we were unable to study
whether that was a determinant of recurrence of MR or not. You
will remember that our LV ejection fraction mean was 22%.
They were all under 30%. So I think this is perhaps a different
means of looking at a very sick patient group.
Dr Dion. Sure. But if you use CMR, it would probably be inter-
esting as well to also look also at the dimensions: obviously you
plan to extend this type of segmental analysis with CMR, which
is a very time-consuming and elaborate task. And if you were
able to link some of your segmental analysis to global LV dimen-
sion, which is easier to measure, it might simplify your work.
Again, I appreciate very much to review this paper and I congrat-
ulate you for an excellent presentation. I thank the Society for the
privilege of discussing it.
Dr Flynn. Thank you, Professor Dion. Thank you very much.1070 The Journal of Thoracic and Cardiovascular SDr D. Adams (New York). Michael, that was an elegant study
and it is important, and it actually correlates with some of your
previous work from your institution about the importance of via-
ble myocardium in predicting a good result after ischemic repair.
So it is logical that a scar burden would also predict failure, and I
think that is important, particularly in your subgroup, which I
would emphasize for the audience had a very low ejection frac-
tion. So these are difficult patients to make decisions about
whether to operate and what to do. This spectrum of ischemic pa-
tients is very difficult.
My question relates to your specific ring strategy, and I think to
understand any results in restrictive disease, we don’t have data, we
don’t have randomized trials, but I just want to understand, were
they downsized, were they rigid, were they complete, and did
your ring strategy evolve over time? This is a relatively current
study, end point 2001 to 2006, and did that make a difference?
Did you see any patterns you can share with us?
Dr Flynn. First, thank you for your comments and your very
good questions. This was a very small study group. There were 7
patients who had complete rings, 22 who had partial rings. Again,
this study was not designed to compare one ring to another. We
found no difference in the rate of recurrence of MR between the
7 patients with a complete versus the 22 who had a partial ring.
We were unable to assess that.
Your second question regarding the method of downsizing, that
was surgeon-specific. There are different methods used at our insti-
tution depending upon the surgeon.
Dr L. Cohn (Boston, Mass). Excellent data presented beauti-
fully. This is similar to what Dr Dor has been advocating for
some time. Magnetic resonance imaging is something that cardiac
surgeons should really adopt, and I suspect that you agree with
that.
Any suggestions based on these data for more effective surgical
therapy? Based on what you have presented to us, have you and
your colleagues at the Cleveland Clinic decided on a more effective
or more strategic way to treat these patients? And what are your cur-
rent, shall we say, thoughts on recent surgical therapy about this
now, based on the data that you presented to us?
Dr Flynn. Dr Cohn, thank you very much for your kind com-
ments. I think this is a very difficult area and a very difficult patient
group. There are various thoughts and theories. I think the thought
of replacing the mitral valve in this patient group with a tissue valve
is one concept, then ventricular restoration is another possibility.
Again, it depends on the severity of LV dysfunction as to how
one would address the ventricular problems. There are other op-
tions. None of them are ideal. As you are aware, it is a very difficult
problem as to how to approach this.urgery c May 2009
Flynn et al Acquired Cardiovascular Disease
A
C
DFIGURE E1. Number of patients with echocardiograms available at various time points across the study and number of echocardiograms available for anal-
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